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Background: The human transcription factors (TFs) GATA4, NKX2.5 and TBX5 form part of the core net-
work necessary to build a human heart and are involved in Congenital Heart Diseases (CHDs). The
human natriuretic peptide precursor A (NPPA) and a-myosin heavy chain 6 (MYH6) genes are downstream
effectors involved in cardiogenesis that have been demonstrated to be in vitro targets of such TFs.
Results: To study the interactions between these human TFs and their target enhancers in vivo, we over-
expressed them in the whole Drosophila cardiac tube using the UAS/GAL4 system. We observed that all
three TFs up-regulate their natural target enhancers in Drosophila and cause developmental defects
when overexpressed in eyes and wings. Conclusions: A strong potential of the present model might be the
development of combinatorial and mutational assays to study the interactions between human TFs and
their natural target promoters, which are not easily undertaken in tissue culture cells because of the vari-
ability in transfection efﬁciency, especially when multiple constructs are used. Thus, this novel system
could be used to determine in vivo the genetic nature of the human mutant forms of these TFs, setting up
a powerful tool to unravel the molecular genetic mechanisms that lead to CHDs. Developmental Dynamics
241:190–199, 2012. V C 2011 Wiley Periodicals, Inc.
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Key ﬁndings:
  The mammalian transcription factors GATA4, Nkx2.5 and TBX5 are able to transactivate the Nppa and
Myh6 human enhancers in Drosophila embryos.
  The endogenous Drosophila homologs of GATA4, Nkx2.5 and TBX5 are not transactivated by GATA4, Nkx2.5
or TBX5, ruling out a possible endogenous regulatory circuit.
  Overexpression in the mesoderm of GATA4, Nkx2.5 or TBX5 is lethal and overexpression in eyes and wings
causes reduced organs.
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INTRODUCTION
The core network of transcription fac-
tors (TFs) and the main events that
lead to heart formation have been con-
served in evolution. The cardiac TFs
GATA4, NKX2.5, and TBX5 are central
to human heart development (Clark
et al., 2006; Olson, 2006; Srivastava,
2006; Nemer, 2008). Mutations in
these genes signiﬁcantly perturb heart
development resulting in Congenital
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sHeart Diseases (CHDs). In Drosophila,
mutations in the homologues of these
genes, tinman (tin;t h eﬂ yNKX2.5
homologue), pannier (pnr;t h eﬂ y
GATA4 homologue), Dorsocross1-3
(Doc1-3; most closely related to Tbx6),
and midline (mid;t h eﬂ yTBX20 homo-
logue), affect the formation of the car-
diac tube (reviewed in Reim and
Frasch, 2010). Mutations in the two
cardiac TFs GATA4 and NKX2.5
impair their functions leading to CHDs
(Schott et al., 1998; Garg et al., 2003).
In humans, TBX5 is essential for heart
and forelimb development and muta-
tions in this gene lead to a develop-
mental disorder called Holt-Oram syn-
drome (Basson et al., 1997; Li et al.,
1997; Mori and Bruneau, 2004). Muta-
tions in TBX5 signiﬁcantly alter its
DNA-binding, protein–protein interac-
tion and transcriptional activities
(Ghosh et al., 2001; Hiroi et al., 2001;
Fan et al., 2003; Garg et al., 2003).
TBX5, alone or in combination with
NKX2.5 and GATA4, regulates the
transcription of NPPA, MYH6 and
CX40, genes that are important for
cardiomyocyte differentiation (Bru-
neau et al., 2001; Hiroi et al., 2001;
Ching et al., 2005). Functional interac-
tions between TBX5 and GATA4 are
important for heart development and
compound heterozygous mice show sig-
niﬁcant down-regulation of Myh6
(Maitra et al., 2009), which encodes a
sarcomeric protein associated with car-
diomyopathy and other congenital
heart disorders (Carniel et al., 2005;
Ching et al., 2005). Cardiac TFs Tbx5
and Gata4 in combination with Baf60c
or Mef2c can also drive ectopic differ-
entiation of mouse mesoderm or ﬁbro-
blast cells into beating cardiac myo-
cytes (Takeuchi and Bruneau, 2009;
Ieda et al., 2010), thereby suggesting
the functional importance of these TFs
and also their potential for future re-
generative medicine.
Although functional cooperation
between these cardiac TFs has been
well documented, to date there are
very few direct targets characterized.
Two well-characterized targets are
NPPA and MYH6. NPPA is a down-
stream target of GATA4 (Durocher
et al., 1997; Lee et al., 1998), NKX2.5
(Durocher et al., 1996), and TBX5
(Hiroi et al., 2001). Mutations in ei-
ther NKX2.5 or TBX5 severely reduce
the transcription of NPPA (Zhu et al.,
2000; Ghosh et al., 2001; Hiroi et al.,
2001; Fan et al., 2003), whereas the
transcription of MYH6 is impaired by
TBX5 or GATA4 mutations (Garg
et al., 2003; Ching et al., 2005). The
enhancers of these genes are invalu-
able tools for understanding the mo-
lecular mechanisms of heart develop-
ment and disorders. Most commonly,
these studies were conducted in
in vitro tissue culture cells following
transfection of the relevant con-
structs. Mutations in these TFs are
pleiotropic and show different degrees
of penetrance. Thus, their in vivo
study in vertebrates is a difﬁcult task.
It is known that regulatory regions
identiﬁed in one organism can func-
tion in a heterologous organism
(Awgulewitsch and Jacobs, 1992;
Malicki et al., 1992; Frasch et al.,
1995; Po ¨pperl et al., 1995; Haerry and
Gehring, 1996, 1997; Keegan et al.,
1997; Xu et al., 1999; Brugger et al.,
2004). For example, the autoregula-
tory elements of Drosophila deformed
and of its mammalian homologue
Hoxb-4 are functionally very con-
served as they are able to function in
each heterologous organism (the ﬂy
homologue in mice and the human
one in ﬂies) (Awgulewitsch and
Jacobs, 1992; Malicki et al., 1992); the
r4 enhancer of mouse Hoxb-1 func-
tions as an auto-regulatory element
in Drosophila embryos (Po ¨pperl et al.,
1995); the eye-speciﬁc enhancer of
Drosophila eyeless directs eye- and
CNS-speciﬁc expression in transgenic
mice and the mouse Pax6 P1
upstream region directs expression in
Drosophila photoreceptors (Xu et al.,
1999). All these examples highlight a
high level of evolutionary conserva-
tion of the transcriptional machinery
between insects and mammals.
In the present work, we show spe-
ciﬁc reporter gene up-regulation of two
human enhancers by the mammalian
TFs GATA4, Nkx2.5, and TBX5 in
Drosophila embryos. Drosophila has
been largely used as a model to study
homologies of signaling and regulatory
pathways that govern organogenesis
in vertebrates and invertebrates. Res-
cue experiments where a Drosophila
TF is replaced by its vertebrate homo-
logue or where a vertebrate regulatory
sequence is activated by a Drosophila
TF have been performed. Neverthe-
less, it is worth mentioning that such
assayed vertebrate regulatory sequen-
ces belong to TFs or to signaling mole-
cules at the top of the pyramid of cues
that lead to organogenesis. On the con-
trary, this has rarely been shown for
downstream effector genes, which are
the actual ‘‘realizators’’ (Garcia Bel-
lido, 1977) of organogenesis. Since
regulatory regions identiﬁed in one or-
ganism might function in a heterol-
ogous organism, we decided to investi-
gate if this could be true also for the
regulatory regions of downstream
effector genes involved in human
cardiogenesis. In this work, we show
that the mammalian TFs GATA4,
Nkx2.5, and TBX5 are able to up-regu-
late their natural target enhancers in
vivo in Drosophila embryos.
RESULTS AND DISCUSSION
In order to determine whether human
enhancers of cardiac realizator genes
could be active in Drosophila, we ﬁrst
selected two human enhancers
belonging to genes that are involved
in a widely described human pathol-
ogy, namely CHDs, the regulation of
which is well known. The two
enhancers belong to the NPPA and
MYH6 human genes. ANF, the prod-
uct of NPPA, is one of the earliest
markers of cardiac differentiation
expressed in the forming ventricular
and atrial chamber myocardium
(Christoffels et al., 2000). The NPPA
promoter has served as a model for
studying the regulatory mechanisms
of cardiac TFs. A number of cardiac
TFs such as GATA4 (Durocher et al.,
1997), NKX2.5 (Durocher et al., 1996)
and TBX5 (Ghosh et al., 2001; Hiroi
et al., 2001) have been shown to inter-
act with an NPPA enhancer. MYH6 is
another important structural and
functional gene mainly expressed in
the atrium (Kurabayashi et al., 1988).
In humans, mutations in this gene
are associated with atrial septal
defects (Ching et al., 2005) and car-
diomyopathy (Carniel et al., 2005).
The MYH6 enhancer is regulated by
the TFs GATA4 (Molkentin et al.,
1994), TBX5 (Ching et al., 2005), and
MEF2 (Ghosh et al., 2009).
In our study, we have used a 300-bp
fragment immediately upstream of
the NPPA promoter (called ANF300)
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IN VIVO HUMAN TFS INVOLVED IN CHDS 191because this enhancer fragment was
shown to be activated in vitro by the
three cardiac-speciﬁc TFs TBX5,
NKX2.5, and GATA4 (Durocher et al.,
1997; Bruneau et al., 2001; Ghosh
et al., 2001). Similarly, the 4.5-Kb
fragment of MYH6 we used has also
been shown to be activated in vitro by
GATA 4 (Molkentin et al., 1994), by
TBX5 (Ching et al., 2005), and by
TBX5 in cooperation with MEF2C
(Ghosh et al., 2009). We cloned the
ANF300 and MYH6 enhancers in the
pH-Stinger vector (Barolo et al.,
2000) upstream of the hs43 promoter
directing nGFP expression. No nGFP
expression was detected in transgenic
embryos by in situ hybridization
(Figs. 1A, B, 2A, B). This indicates
that wild-type levels of Drosophila
TFs are unable to up-regulate these
two enhancers either because the lev-
els of GFP expression driven by the
endogenous TFs are too low to be
detected or because the endogenous
TFs are busy taking care of their nor-
mal targets (a sort of threshold
effect). By contrast, the over-expres-
sion of GATA4, Nkx2.5,o rTBX5 in
embryos using the UAS/GAL4 system
(Brand and Perrimon, 1993) speciﬁ-
cally activated nGFP in the same
way through both the ANF300 (Fig.
1) and MYH6 (Fig. 2) enhancers.
When the three TFs are over-
expressed through the Hand-GAL4
driver (Albrecht et al., 2006; Sellin
et al., 2006), GFP expression is
detected in the cardiac tube and in
the visceral mesoderm (Figs. 1E–J,
2E–J), in the same domains as UAS-
GFP expression (Figs. 1C,D, 2C,D).
This indicates that the three human
TFs are able to up-regulate their
human targets in Drosophila and
that MYH6 is a putative target of
Nkx2.5, which has not been reported
before. No GFP expression was
observed in embryos carrying only
the reporter and the Hand-GAL4
driver (Figs. 1A,B, 2A,B) or when
over-expression was achieved in the
Central Nervous System with the
elav-GAL4 driver (data not shown),
which did not lead to lethality.
We extracted mRNA from the
embryos of the same genotypes as
those used for the in situ hybridiza-
tion shown in Figure 1. We reverse-
transcribed it and used it as a tem-
plate in PCR reactions ampliﬁed with
GFP oligonucleotides. We did not
observe any ampliﬁcation product in
embryos carrying only the reporter
and the Hand-GAL4 transgenes (Fig.
3A, lane 3), whereas we detected a
speciﬁc band of the expected GFP size
(Fig. 3A, lane 7) in the embryos that
also carry the UAS-GATA4, UAS-
Nkx2.5,o rUAS-TBX5 effector con-
structs (Fig. 3A, lanes 4–6). The rp49
housekeeping control indicates that
cDNA is equally present in all sam-
ples (Fig. 3B). The same RT-PCR
experiment has been done for the
MYH6 enhancer and gave the same
results (data not shown). Thus, GFP
is indeed up-regulated by the three
TFs considered.
Fig. 1. GATA4, Nkx2.5, and TBX5 transactivate the ANF300 enhancer in Drosophila embryos.
Detection of GFP expression driven by the ANF300 enhancer by in situ hybridization using HRP
staining. All embryos are shown with the anterior end to the left. Left column: Stage 3–14
embryos. Right column: Stage 15–16 embryos (dorsal side up). All embryos carry the ANF-
hs43-nGFP reporter and the Hand-GAL4 driver. In wild-type embryos (A, B), no GFP is detected.
In embryos carrying also the UAS-GFP (C, D), UAS-GATA4 (E, F), UAS-Nkx2.5 (G, H), or UAS-
TBX5 (I, J) transgene, GFP is detected in the cardiac tube (block arrows) and in the visceral
mesoderm (arrows). Staining with the sense GFP probe did not produce any signal except for
salivary glands (arrowheads, data not shown).
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192 AMODIO ET AL.The Drosophila system we propose
allows analyzing the functions of
human TFs in vivo. In vitro, not all
cell types are transfected with the
same efﬁciency and, in some instan-
ces, overexpression of the TFs causes
spurious activity. Using Drosophila
transgenics as a model overrides vari-
ability, for example due to transfec-
tion efﬁciency, because in transgenic
ﬂies all the cells in a tissue carry both
the reporter and the effector con-
structs, which are up-regulated all at
the same level through the UAS/
GAL4 system. Consequently, in this
system the molecular interactions
observed can be studied at a higher
level of precision. In addition, a
strong potential of the present model
might come from the combinatorial
and mutational assays of TFs on their
target promoters, which are not easily
undertaken in tissue culture cells
because of the variability in transfec-
tion efﬁciency especially when multi-
ple constructs are used.
pnr and tin are the ﬂy homologues
of human GATA4 and NKX2.5,
respectively. The Drosophila pnr, tin,
and Tbx genes are known to auto-reg-
ulate and to cross-regulate each other
(Gajewski et al., 2001; Klinedinst and
Bodmer, 2003; Qian et al., 2005; Reim
and Frasch, 2005; Reim et al., 2005).
Similarly, NKX2.5 regulates the
expression of human GATA4 (Riazi
et al., 2009) and GATA4 also regulates
transcription of NKX2.5 through an
upstream NKX2.5 enhancer (Lien
et al., 1999). So far, there is no report
on an autoregulatory role for NKX2.5
and GATA4. To rule out a possible en-
dogenous regulatory circuit, we ﬁrst
determined whether tin (the ﬂy homo-
logue of NKX2.5) is able to up-regu-
late the ANF300 and MYH6
enhancers. Figure 4 shows the up-
regulation of the two enhancers by
overexpression of either Nkx2.5 or tin
in the whole mesoderm using the
24B-GAL4 driver, which directs
expression in the whole mesoderm
(Fig. 4; see Supp. Fig. S1, which is
available online) (Zaffran et al.,
1997). Thus, Tin has the same regula-
tory ability as its Nkx2.5 homologue
in the regulation of the ANF300 and
MYH6 enhancers. GATA4, Nkx2.5,
Fig. 2. GATA4, Nkx2.5, and TBX5 transactivate the MYH6 enhancer in Drosophila embryos.
Detection of GFP expression driven by the MYH6 enhancer by in situ hybridization using HRP
staining. Left column: Stage-13–14 embryos. Right column: Stage-15–16 embryos (dorsal side
up). All embryos carry the MYH6-hs43-nGFP reporter and the Hand-GAL4 driver. In wild-type
embryos (A, B), no GFP is detected. In embryos carrying also the UAS-GFP (C, D), UAS-GATA4
(E, F), UAS-Nkx2.5 (G, H), or UAS-TBX5 (I, J) transgene, GFP is detected in the cardiac tube
(block arrows) and in the visceral mesoderm (arrows). Staining with the sense GFP probe did
not produce any signal except for salivary glands (arrowheads, data not shown).
Fig. 3. Detection of GFP by RT-PCR. RT-
PCR was performed on the same embryos as
those of Figure 1. A: RT-PCR detection of
GFP. B: RT-PCR detection of the rp49 house-
keeping gene. 1, mock PCR; 2, white;3 ,
Hand-GAL4; ANF300MYH6-hs43-nGFP;4 ,
Hand-GAL4; ANF300MYH6-hs43-nGFP þ
UAS-GATA4;5 ,Hand-GAL4; ANF300MYH6-
hs43-nGFP þ UAS-Nkx2.5;6 ,Hand-GAL4;
ANF300MYH6-hs43-nGFP þ UAS-TBX5;7 ,
Hand-GAL4; ANF300MYH6-hs43-nGFP þ
UAS-GFP. A specific GFP band is detected
only in GATA4, Nkx2.5, and TBX5 overex-
pressing embryos (lanes 4–6) and in the posi-
tive control (lane 7).
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IN VIVO HUMAN TFS INVOLVED IN CHDS 193and TBX5 could up-regulate the two
enhancers through the indirect acti-
vation of their ﬂy homologues. To rule
out this possibility, we looked at the
expression of the ﬂy endogenous
genes pnr (GATA4 homologue), tin
(NKX2.5 homologue), midline (TBX20
homologue), and Doc1 (TBX6 homo-
logue; there is no true Drosophila
homologue of TBX5) in embryos
ectopically activating GATA4, Nkx2.5,
or TBX5.B yin situ hybridization (for
pnr, Doc1, and mid) or immunohisto-
chemistry (for tin), we did not see a
change in expression of these endoge-
nous ﬂy genes in germ band–extended
and in germ band–retracted embryos
upon GATA4, Nkx2.5,o rTBX5 over-
expression in the cardiac, somatic,
and visceral mesoderm through the
24B-GAL4 driver (Fig. 5). This indi-
cates that the regulation of the two
tested enhancers by the three mam-
malian TFs is not indirect.
Several human and murine
enhancers have been shown to be
active in Drosophila. Most of the re-
porter constructs used in the regula-
tory studies on the evolutionary con-
servation of enhancers reported in the
Introduction section (Awgulewitsch
and Jacobs, 1992; Malicki et al., 1992;
Frasch et al., 1995; Po ¨pperl et al.,
1995; Haerry and Gehring, 1996,
1997; Keegan et al., 1997; Xu et al.,
1999; Brugger et al., 2004) utilized
the TATA promoter hs43 (the Dro-
sophila hsp70 promoter deleted of the
Pelham heat-inducible box) that we
used in our studies. This promoter is
silent in Drosophila. It has been used
in numerous studies on many types of
Drosophila and mammalian TFs over
many years (Qian et al., 1991, 1993;
Capovilla et al., 1994; Chan et al.,
1994; Capovilla and Botas, 1998; Hir-
omi and Gehring, 1987; Wagner-Bern-
holz et al., 1991; Vachon et al., 1992;
Gajewski et al., 1997; Ranganayakulu
et al., 1998; Li et al., 1999; Ryoo et al.,
1999; Han et al., 2002; Sellin et al.,
2006; Ryan et al., 2007). In addition,
several mammalian TFs have been
shown to function in Drosophila as
their ﬂy homologues (Luo et al., 1992;
Albagli et al., 1996; Ludlow et al.,
1996; Deshpande et al., 1997; Leu-
zinger et al., 1998; Nagao et al., 1998;
D’Souza et al., 1999; Fox et al., 2010).
In most of these studies, the Drosoph-
ila or mammalian TFs were over-
expressed through the UAS/GAL4
method we used. Thus, it is very
likely that the GFP expression we
observed comes from a direct interac-
tion between the TFs over-expressed
and the two human enhancers stud-
ied, which is supported by the results
reported in Figure 5. To our knowl-
edge, this is the ﬁrst report of human
enhancers being activated by human
TFs in ﬂies and it highlights the high
evolutionary conservation of the regu-
latory functions of these molecules.
We determined whether GATA4,
Nkx2.5,o rTBX5 over-expression
could cause developmental defects. To
this aim, we over-expressed the three
TFs in the whole mesoderm (through
the 24B-GAL4 driver), in the eyes
(through the GMR-GAL4 driver), and
Fig. 4. tin overexpression transactivates the ANF300 and MYH6 enhancers. Detection of GFP expression driven by the ANF300 and MYH6
enhancers upon tin overexpression by in situ hybridization. Left two columns: Germ band–extended embryos. Right two columns: Germ band–
retracted embryos. Embryos carrying only the reporter and GAL4 transgenes (top row) do not show GFP expression. Embryos overexpressing
GFP (second row), Nkx2.5 (third row), or tin (fourth row) through the 24B-GAL4 driver show GFP expression in the somatic and visceral (arrows)
mesoderm. Overexpression of tin is detected by immunohistochemistry using anti-Tin antibodies (bottom row).
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194 AMODIO ET AL.in the wings (through the vestigial-
GAL4 driver). Over-expression of each
of the three TF in the mesoderm is le-
thal. Over-expression in eyes and
wings causes developmental defects,
as both are very reduced (Fig. 6). For
GMR-GAL4, the penetrance is com-
plete at 28 C and at 18 C for all three
TFs (Supp. Fig. S2). At 18 C, the over-
expression of Nkx2.5 in the eye shows
variable expressivity (data not
shown). Finally, we observed that very
similar phenotypes in both eyes and
wings are elicited by the overexpres-
sion of pnr (with 100% penetrance at
all temperatures), but not of tin (data
not shown). This is consistent with the
fact that GATA4 is the true orthologue
of pnr (Gajewski et al., 1999), whereas
Nkx2.5 is not able to functionally
replace tin in all its developmental
roles (Park et al., 1998; Ranganaya-
kulu et al., 1998). The fact that over-
expression of the three TFs leads to
the same developmental defects sug-
gests that they act in the same devel-
opmental pathway. Because the phe-
notypes elicited are viable and very
easy to score, the over-expression of
these TFs could be used to carry out
modiﬁer screens in order to identify
novel interactors, as as it has been
successfully done for other gene prod-
ucts (Fernandez-Funez et al., 2000;
Bilen and Bonini, 2007; Cukier et al.,
2008; Jung et al., 2010).
Fig. 5. Endogenous Drosophila TFs are not mis-expressed by the over-expression of GATA4, Nkx2.5,o rTBX5. Detection of tin protein by immu-
nohistochemistry and of pnr, Doc1, and mid transcripts by in situ hybridization in control embryos (top) and in embryos overexpressing GATA4,
Nkx2.5,o rTBX5 (see left) in the whole mesoderm through the 24B-GAL4 driver. A: Germ band–extended embryos. B: Germ band–retracted
embryos. Each gene is expressed at normal levels in all embryos.
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IN VIVO HUMAN TFS INVOLVED IN CHDS 195To our knowledge, this is the ﬁrst
report of human TFs regulating their
natural downstream effector targets
in Drosophila. This system might be
used to carry out structural/func-
tional studies for combinatorial analy-
ses of multiple TFs that would not be
easily undertaken in vitro, because
transfection efﬁciency is limiting
when more than two factors are
transfected. This assay may allow
determining clearly the genetic func-
tions of mutant forms of these TFs or
of their targets involved in CHDs, to
deﬁne unambiguously in vivo their
inter-relationships and genetic fea-
tures (e.g., dominance), which may
help to understand the different phe-
notypes observed among CHDs
patients.
EXPERIMENTAL
PROCEDURES
Plasmid Construction and
Transgenic Flies
The ANF 300-bp enhancer fragment
was ampliﬁed from the pGL3 ANF300
plasmid (Ghosh et al., 2001) using the
oligonucleotides 50-GGTCTAGACAGC
GTCGAGGAGAAAGAAT-30 (carrying
a XbaI site) and 50-TTGGATCCAGC
TCTCCAAGCACGCAG-30 (carrying a
BamHI site). The 4.5-kb MYH6
enhancer was ampliﬁed from the
pGL3 MYH6 4.5 plasmid (Ching
et al., 2005) using the oligonucleotides
50-CCTCTAGAGAAGCCGAGATCCT
GACTCCAGACTCTTCT-30 (carrying
aX b a Is i t e )a n d5 0-CCGGATCCCCT
CTGTCTAAATTTGGAGTCCTTCCGG
AG-30 (carrying a BamHI site). Both
enhancers were cloned in the XbaI
and BamHI sites of pH-Stinger (Bar-
olo et al., 2000) upstream of the mini-
mal hs43 promoter driving nGFP
expression to generate the ANF300-
hs43-nGFP and MYH6-hs43-nGFP
reporters.
To generate the UAS-GATA4 con-
struct, the GATA4 cDNA was excised
from pcDNA3.1 Zeo(-) GATA4 (T. K.
Ghosh, unpublished data) with EcoRI
and cloned in the EcoRI site of pUAST
(Brand and Perrimon, 1993). The ori-
entation was veriﬁed with BamHI to
select a clone with the orientation
appropriate for protein synthesis. The
TBX5 cDNA was excised from
pcDNA.1zeo(þ) TBX5 (Ghosh et al.,
2001) with XhoI and EcoRI and
cloned in the NheI and BamHI sites
of pBluescript KSþ. From this con-
struct, it was then excised using NotI
and KpnI and cloned in the NotI and
KpnI sites of pUAST to generate
UAS-TBX5. ANF300-hs43-nGFP, and
MYH6-hs43-nGFP transgenic ﬂies
were generated in the laboratory by
standard methods. UAS-GATA4 and
UAS-TBX5 transgenic ﬂies were gen-
erated by Best Gene Inc. (Chino Hills,
CA). UAS-Nkx2.5 (Zaffran et al.,
2006) ﬂies and UAS-tin ﬂies (Yin and
Frasch, 1998) were a gift of Manfred
Frasch. At least two independent re-
porter and UAS lines were analyzed
for each experiment.
The GAL4 lines used are: Hand-
GAL4 (Albrecht et al., 2006; Sellin et
al., 2006), P{GawB}how[24B] (24B-
GAL4), GMR-GAL4, elav-GAL4,a n d
vestigial-GAL4.
Crosses and Embryo Staining
Double-balanced Hand-GAL4;
ANF300-hs43-nGFP and Hand-
GAL4; MYH6-hs43-nGFP stocks were
generated by standard procedures.
Males of these stocks were crossed to
UAS-GFP (Blooomington stock n.
1521), UAS-GATA4, UAS-Nkx2.5,o r
UAS-TBX5 females at 27 C. Progeny
embryos were dechorionated in 50%
bleach, ﬁxed in 4% formaldehyde,
devitellinized in 100% methanol, and
stored in 100% ethanol. All probes
were made using the Riboprobe Com-
bination System kit (Promega, Madi-
son, WI) and the DIG RNA Labeling
Mix (Roche, Indianapolis, IN). To
make GFP probes, the GFP cDNA
was excised from pStinger (Barolo
et al., 2000) with EcoRI and XbaI and
cloned in the EcoRI and XbaI sites of
pGEM. GFP sense and antisense
probes were made by linearizing with
HindIII and transcribing with SP6 or
by linearizing with EcoRI and tran-
scribing with T7, respectively. The
Doc2, mid, and pnr antisense probes
were made as follows: the Doc2
cDNA cloned in pNB40 (Reim et al.,
2003) was linearized with SmaI and
transcribed with T7, the mid cDNA
plasmid cloned in pFLC (Reim et al.,
2005) was linearized with XhoI and
transcribed with T3, and the pnr
cDNA plasmid (Ramain et al., 1993)
cloned in pBluescript was linearized
with HindIII and transcribed with
T3. Embryos were stained using the
TSA Plus Biotin System (Perkin
Elmer, Waltham, MA) with minor
modiﬁcations available upon request.
Immunohistochemistry was carried
out as previously described (Capovilla
et al., 2001) with anti-Tin antibodies
(Yin et al., 1997) at a 1:1,000
dilution.
RT PCR
Total RNA was extracted from 30 mlo f
dechorionated 12–24-hr embryos using
PureZOL RNA Isolation Reagent (Bio-
Rad, Hercules, CA) following instruc-
tions. cDNAwas produced from 1 mgo f
total RNA digested with DNaseI using
the iScript cDNA Synthesis kit (Bio-
Rad) according to instructions. PCR
was carried out using the following pri-
mers: GFP-For (50-TGACCCTGAACTT
CATCTG-30), GFP-Rev (50-GCTGTTGT
AGTTGTACTC-30), RP49-For (50-TAT
GCTAAGCTGTCGCAC-30), and RP49-
Rev (50-ATCCGTAACCGATGTTGG-30)
using DreamTaq DNA Polymerase
(Fermentas Life Sciences, Glen Bur-
nie, MD).
Fig. 6. Developmental defects caused by
GAT4, Nkx2.5,o rTBX5 over-expression in
eyes and in wings. Reduced eyes and wings
caused by the overexpression of GATA4 (C,
D), Nkx2.5 (E, F)o rTBX5 (G, H) in the eye
through the GMR-GAL4 driver (C, E, G) or in
the wing through the vg-GAL4 driver (D, F, H).
Top: Control flies carrying only the GMR-GAL4
(A)o rvg-GAL4 (B) drivers. All flies were
raised at 27 C, but phenotypic effects were
visible also at 18 C (data not shown and
Supp. Fig. S2).
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